Bioxyne Ltd (BXN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bioxyne Ltd (BXN) has a cash flow conversion efficiency ratio of -0.064x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.29 Million ≈ $-915.87K USD) by net assets (AU$20.17 Million ≈ $14.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioxyne Ltd - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Bioxyne Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Bioxyne Ltd for a breakdown of total debt and financial obligations.
Bioxyne Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioxyne Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dharmaj Crop Guard Limited
NSE:DHARMAJ
|
0.001x |
|
BMT Co. Ltd
KQ:086670
|
0.034x |
|
Blink Charging Co
NASDAQ:BLNK
|
-0.033x |
|
R. Stahl AG NA O.N.
F:RSL2
|
0.055x |
|
Bridgemarq Real Estate Services Inc
TO:BRE
|
-0.014x |
|
ENERGY TRANSITION MINERAL
F:G7PA
|
N/A |
|
Intertek Group PLC
LSE:ITRK
|
0.124x |
|
Igis Residence Reit Co Ltd
KO:350520
|
N/A |
Annual Cash Flow Conversion Efficiency for Bioxyne Ltd (2000–2025)
The table below shows the annual cash flow conversion efficiency of Bioxyne Ltd from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Bioxyne Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$11.38 Million ≈ $8.05 Million |
AU$6.28 Million ≈ $4.44 Million |
0.552x | +151.14% |
| 2024-06-30 | AU$3.30 Million ≈ $2.33 Million |
AU$-3.56 Million ≈ $-2.52 Million |
-1.079x | -1331.48% |
| 2023-06-30 | AU$15.01 Million ≈ $10.62 Million |
AU$-1.13 Million ≈ $-800.27K |
-0.075x | -105.43% |
| 2022-06-30 | AU$-364.84K ≈ $-258.15K |
AU$-506.81K ≈ $-358.60K |
1.389x | +4955.72% |
| 2021-06-30 | AU$1.93 Million ≈ $1.37 Million |
AU$53.13K ≈ $37.60K |
0.027x | +48.59% |
| 2020-06-30 | AU$2.61 Million ≈ $1.85 Million |
AU$48.25K ≈ $34.14K |
0.018x | +104.18% |
| 2019-06-30 | AU$3.14 Million ≈ $2.22 Million |
AU$-1.39 Million ≈ $-983.77K |
-0.442x | -3.07% |
| 2018-06-30 | AU$4.32 Million ≈ $3.06 Million |
AU$-1.86 Million ≈ $-1.31 Million |
-0.429x | -318.22% |
| 2017-06-30 | AU$4.13 Million ≈ $2.92 Million |
AU$-424.05K ≈ $-300.04K |
-0.103x | -145.65% |
| 2016-06-30 | AU$1.55 Million ≈ $1.10 Million |
AU$348.85K ≈ $246.84K |
0.225x | +273.10% |
| 2015-06-30 | AU$1.28 Million ≈ $908.28K |
AU$-166.77K ≈ $-118.00K |
-0.130x | -122.95% |
| 2014-06-30 | AU$1.07 Million ≈ $758.45K |
AU$606.76K ≈ $429.32K |
0.566x | -87.72% |
| 2013-06-30 | AU$-210.73K ≈ $-149.10K |
AU$-971.70K ≈ $-687.54K |
4.611x | +678.23% |
| 2012-06-30 | AU$5.89 Million ≈ $4.17 Million |
AU$-4.70 Million ≈ $-3.32 Million |
-0.797x | -29.84% |
| 2011-06-30 | AU$124.34K ≈ $87.98K |
AU$-76.37K ≈ $-54.04K |
-0.614x | -149.79% |
| 2010-06-30 | AU$123.29K ≈ $87.23K |
AU$152.07K ≈ $107.60K |
1.233x | +110.83% |
| 2009-06-30 | AU$43.15K ≈ $30.53K |
AU$-491.48K ≈ $-347.75K |
-11.391x | -751.42% |
| 2008-06-30 | AU$-623.12K ≈ $-440.90K |
AU$-1.09 Million ≈ $-770.99K |
1.749x | +128.21% |
| 2007-06-30 | AU$218.65K ≈ $154.71K |
AU$-1.36 Million ≈ $-958.87K |
-6.198x | -12.44% |
| 2006-06-30 | AU$410.58K ≈ $290.51K |
AU$-2.26 Million ≈ $-1.60 Million |
-5.512x | +71.34% |
| 2005-06-30 | AU$186.98K ≈ $132.30K |
AU$-3.60 Million ≈ $-2.54 Million |
-19.232x | -365.33% |
| 2004-06-30 | AU$1.18 Million ≈ $831.58K |
AU$-4.86 Million ≈ $-3.44 Million |
-4.133x | +19.97% |
| 2003-06-30 | AU$967.78K ≈ $684.77K |
AU$-5.00 Million ≈ $-3.54 Million |
-5.164x | -386.06% |
| 2002-06-30 | AU$4.26 Million ≈ $3.01 Million |
AU$-4.52 Million ≈ $-3.20 Million |
-1.063x | -228.39% |
| 2001-06-30 | AU$9.02 Million ≈ $6.39 Million |
AU$-2.92 Million ≈ $-2.07 Million |
-0.324x | -258.68% |
| 2000-06-30 | AU$12.43 Million ≈ $8.80 Million |
AU$-1.12 Million ≈ $-793.44K |
-0.090x | -- |
About Bioxyne Ltd
Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Onlin… Read more